India may overhaul clinical trial ecosystem for faster drug availability

Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. The trials, to be held by the Indian Council of Medical Research (ICMR), could be the beginning of an overhaul of the clinical trial ecosystem.  The government has rarely ventured into this arena before. Clinical trials for new drugs have so far primarily been conducted only by private Indian or foreign drug firms. But given the stringent nature of India’s regulatory environment for clinical trials, .....

Key stories on business-standard.com are available to premium subscribers only.

Already a premium subscriber?

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.